Together, Changing Sarcoidosis's Future
Foundation for Sarcoidosis Research (stopsarcoidosis.org) scores 77 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Non-profit brands, in the 59th percentile of 20426 Healthcare brands.
Foundation for Sarcoidosis Research (FSR) is a nonprofit organization based in Chicago, United States, founded in 2000. Its mission is to accelerate research and improve outcomes for sarcoidosis patients worldwide through patient-centered initiatives. FSR connects leading sarcoidosis experts with research funding and educational programs, aiming to bridge scientific innovation with real-world patient support. The organization serves patients, families, medical researchers, healthcare providers, and donors interested in advancing rare disease research, positioning itself as a global leader in sarcoidosis-focused research and advocacy.
| Brand Name | Foundation for Sarcoidosis Research |
|---|---|
| Domain | stopsarcoidosis.org |
| Industry | Healthcare, Non-profit |
| Founded | 2000 |
| Headquarters | Chicago, United States |
| Main Competitors | Sarcoidosis UK (75/100), World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG), National Organization for Rare Disorders (NORD) (86/100), American Lung Association (90/100), Pulmonary Fibrosis Foundation (82/100) |
Moz Domain Authority 51/100 vs category average 40 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #1,361,444 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "This is a description for the homepage." (Meta description: 7 words. No OG description (falling back to meta)) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 2 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: WordPress, Ghost.
Social footprint: verified profiles on X (Twitter), YouTube, Instagram; no detected presence on Facebook, LinkedIn, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is Foundation for Sarcoidosis Research?", Claude could identify the brand as of October 2026. The Foundation for Sarcoidosis Research (FSR) is a nonprofit organization dedicated to funding research into sarcoidosis, a rare inflammatory disease, while also providing patient support and education. It works to improve diagnosis and treatment options and raises awareness thro Best known for Being the leading nonprofit funding sarcoidosis research and supporting patients with the disease.
When asked "Best brands similar to Foundation for Sarcoidosis Research?", Claude would recommend Foundation for Sarcoidosis Research as of October 2026. It's the most prominent and credible organization specifically focused on sarcoidosis research and patient support, making it a natural recommendation for anyone looking into this disease.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Foundation for Sarcoidosis Research's main competitors in Healthcare: Sarcoidosis UK (75/100), National Organization for Rare Disorders (NORD) (86/100), American Lung Association (90/100), Pulmonary Fibrosis Foundation (82/100).
Sources: Brand Analyzer scan
Foundation for Sarcoidosis Research (FSR) is a nonprofit organization headquartered in Chicago, United States, founded in 2000. It is dedicated to advancing research, education, and patient support related to sarcoidosis, a rare inflammatory disease. FSR works to connect scientific experts, healthcare providers, and patients to improve understanding and treatment of the condition on a global scale.
Foundation for Sarcoidosis Research has limited AI-search visibility, scoring 37/100 on Brand Analyzer's AI visibility composite (visibility 21, trust 46, recommendation 56). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Foundation for Sarcoidosis Research was founded in 2000. Foundation for Sarcoidosis Research operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Foundation for Sarcoidosis Research scores 56/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Foundation for Sarcoidosis Research can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
FSR offers research funding programs for sarcoidosis studies, patient education resources, and initiatives that connect medical experts with patients and healthcare providers. Its offerings are centered on advancing scientific knowledge of sarcoidosis and translating that knowledge into practical support for patients.
FSR serves sarcoidosis patients and their families seeking information and support, medical researchers studying the disease, healthcare providers treating sarcoidosis patients, and donors who wish to support rare disease research. The organization acts as a connective resource across these groups.
Foundation for Sarcoidosis Research scores 37/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Foundation for Sarcoidosis Research has a weak AI-visibility profile at 37/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (56/100) and its weakest is visibility (21/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #1,361,444 (Tranco) and a Moz Domain Authority of 51/100. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Foundation for Sarcoidosis Research from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Foundation for Sarcoidosis Research: Stevenage Bioscience Catalyst (77/100), Stanson Health (77/100), Straight Teeth Direct (77/100), Strand Life Sciences (77/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.